메뉴 건너뛰기




Volumn 38, Issue 7, 2009, Pages 791-798

Serum REG4 level is a predictive biomarker for the response to preoperative chemoradiotherapy in patients with pancreatic cancer

Author keywords

Biomarker; Chemoradiotherapy; Gemcitabine; Prediction; REG4

Indexed keywords

BIOLOGICAL MARKER; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; COMPLEMENTARY DNA; GEMCITABINE; PROTEIN; REG IV PROTEIN; REGENERATING ISLET DERIVED FAMILY OF PROTEINS; TUMOR MARKER; UNCLASSIFIED DRUG;

EID: 70349934514     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181ac5337     Document Type: Article
Times cited : (35)

References (34)
  • 1
    • 18844453135 scopus 로고    scopus 로고
    • Surgery for pancreatic cancer: Recent controversies and current practice
    • Wray CJ, Ahmad SA, Matthews JB, et al. Surgery for pancreatic cancer: recent controversies and current practice. Gastroenterology. 2005;128: 1626-1641.
    • (2005) Gastroenterology , vol.128 , pp. 1626-1641
    • Wray, C.J.1    Ahmad, S.A.2    Matthews, J.B.3
  • 2
    • 0032760453 scopus 로고    scopus 로고
    • AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma
    • American Gastroenterological Association
    • DiMagno EP, Reber HA, Tempero MA. AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association. Gastroenterology. 1999;117:1464-1484.
    • (1999) Gastroenterology , vol.117 , pp. 1464-1484
    • DiMagno, E.P.1    Reber, H.A.2    Tempero, M.A.3
  • 3
    • 0028799366 scopus 로고
    • The National Cancer Data Base report on pancreatic cancer
    • Niederhuber JE, Brennan MF, Menck HR. The National Cancer Data Base report on pancreatic cancer. Cancer. 1995;76:1671-1677.
    • (1995) Cancer , vol.76 , pp. 1671-1677
    • Niederhuber, J.E.1    Brennan, M.F.2    Menck, H.R.3
  • 4
    • 0032985541 scopus 로고    scopus 로고
    • Pancreatic cancer: A report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database
    • Sener SF, Fremgen A, Menck HR, et al. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg. 1999;189:1-7.
    • (1999) J Am Coll Surg , vol.189 , pp. 1-7
    • Sener, S.F.1    Fremgen, A.2    Menck, H.R.3
  • 5
    • 0028888708 scopus 로고
    • Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?
    • Nitecki SS, Sarr MG, Colby TV, et al. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg. 1995;221:59-66.
    • (1995) Ann Surg , vol.221 , pp. 59-66
    • Nitecki, S.S.1    Sarr, M.G.2    Colby, T.V.3
  • 6
    • 0029956221 scopus 로고    scopus 로고
    • Survival after resection for ductal adenocarcinoma of the pancreas
    • DOI 10.1002/bjs.1800830512
    • Sperti C, Pasquali C, Piccoli A, et al. Survival after resection for ductal adenocarcinoma of the pancreas. Br J Surg. 1996;83:625-631. (Pubitemid 26163547)
    • (1996) British Journal of Surgery , vol.83 , Issue.5 , pp. 625-631
    • Sperti, C.1    Pasquali, C.2    Piccoli, A.3    Pedrazzoli, S.4
  • 7
    • 49049101358 scopus 로고    scopus 로고
    • Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head
    • Evans DB, Varadhachary GR, Crane CH, et al. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol. 2008;26: 3496-3502.
    • (2008) J Clin Oncol , vol.26 , pp. 3496-3502
    • Evans, D.B.1    Varadhachary, G.R.2    Crane, C.H.3
  • 8
    • 38149108387 scopus 로고    scopus 로고
    • Neoadjuvant chemoradiation in patients with potentially resectable pancreatic cancer
    • Takai S, Satoi S, Yanagimoto H, et al. Neoadjuvant chemoradiation in patients with potentially resectable pancreatic cancer. Pancreas. 2008; 36:e26-32.
    • (2008) Pancreas , vol.36
    • Takai, S.1    Satoi, S.2    Yanagimoto, H.3
  • 9
    • 39749174027 scopus 로고    scopus 로고
    • Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: A multicenter phase II trial
    • Small W Jr, Berlin J, Freedman GM, et al. Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial. J Clin Oncol. 2008;26:942-947.
    • (2008) J Clin Oncol , vol.26 , pp. 942-947
    • Small Jr., W.1    Berlin, J.2    Freedman, G.M.3
  • 15
    • 0037317521 scopus 로고    scopus 로고
    • The role of p53 in determining sensitivity to radiotherapy
    • Gudkov AV, Komarova EA. The role of p53 in determining sensitivity to radiotherapy. Nat Rev Cancer. 2003;3:117-129.
    • (2003) Nat Rev Cancer , vol.3 , pp. 117-129
    • Gudkov, A.V.1    Komarova, E.A.2
  • 16
    • 0345256634 scopus 로고    scopus 로고
    • The role of p53 in chemosensitivity and radiosensitivity
    • El-Deiry WS. The role of p53 in chemosensitivity and radiosensitivity. Oncogene. 2003;22:7486-7495.
    • (2003) Oncogene , vol.22 , pp. 7486-7495
    • El-Deiry, W.S.1
  • 17
    • 40749094856 scopus 로고    scopus 로고
    • Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer
    • DOI 10.1016/S1470-2045(08)70073-1, PII S1470204508700731
    • Bussink J, van der Kogel AJ, Kaanders JH. Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer. Lancet Oncol. 2008;9:288-296. (Pubitemid 351722948)
    • (2008) The Lancet Oncology , vol.9 , Issue.3 , pp. 288-296
    • Bussink, J.1    Van Der Kogel, A.J.2    Kaanders, J.H.3
  • 23
    • 26044463766 scopus 로고    scopus 로고
    • Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma
    • DOI 10.1002/path.1827
    • Oue N, Mitani Y, Aung PP, et al. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma. J Pathol. 2005;207:185-198. (Pubitemid 41404149)
    • (2005) Journal of Pathology , vol.207 , Issue.2 , pp. 185-198
    • Que, N.1    Mitani, Y.2    Aung, P.P.3    Sakakura, C.4    Takeshima, Y.5    Kaneko, M.6    Noguchi, T.7    Nakayama, H.8    Yasui, W.9
  • 24
    • 33748932541 scopus 로고    scopus 로고
    • Novel tumor marker REG4 detected in serum of patients with resectable pancreatic cancer and feasibility for antibody therapy targeting REG4
    • DOI 10.1111/j.1349-7006.2006.00297.x
    • Takehara A, Eguchi H, Ohigashi H, et al. Novel tumor marker REG4 detected in serum of patients with resectable pancreatic cancer and feasibility for antibody therapy targeting REG4. Cancer Sci. 2006;97: 1191-1197. (Pubitemid 44430644)
    • (2006) Cancer Science , vol.97 , Issue.11 , pp. 1191-1197
    • Takehara, A.1    Eguchi, H.2    Ohigashi, H.3    Ishikawa, O.4    Kasugai, T.5    Hosokawa, M.6    Katagiri, T.7    Nakamura, Y.8    Nakagawa, H.9
  • 25
    • 30044442435 scopus 로고    scopus 로고
    • Reg IV activates the epidermal growth factor receptor/Akt/AP-1 signaling pathway in colon adenocarcinomas
    • DOI 10.1053/j.gastro.2005.10.001, PII S001650850502010X
    • Bishnupuri KS, Luo Q, Murmu N, et al. Reg IV activates the epidermal growth factor receptor/Akt/AP-1 signaling pathway in colon adenocarcinomas. Gastroenterology. 2006;130:137-149. (Pubitemid 43049844)
    • (2006) Gastroenterology , vol.130 , Issue.1 , pp. 137-149
    • Bishnupuri, K.S.1    Luo, Q.2    Murmu, N.3    Houchen, C.W.4    Anant, S.5    Dieckgraefe, B.K.6
  • 27
    • 0026454511 scopus 로고
    • Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas
    • Evans DB, Rich TA, Byrd DR, et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg. 1992;127:1335-1339.
    • (1992) Arch Surg , vol.127 , pp. 1335-1339
    • Evans, D.B.1    Rich, T.A.2    Byrd, D.R.3
  • 30
    • 0034009704 scopus 로고    scopus 로고
    • Decrease of CA 19-9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer
    • Halm U, Schumann T, Schiefke I, et al. Decrease of CA 19-9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer. Br J Cancer. 2000;82:1013-1016. (Pubitemid 30128852)
    • (2000) British Journal of Cancer , vol.82 , Issue.5 , pp. 1013-1016
    • Halm, U.1    Schumann, T.2    Schiefke, I.3    Witzigmann, H.4    Mossner, J.5    Keim, V.6
  • 31
    • 0030273040 scopus 로고    scopus 로고
    • CA 19-9 is an index of response to neoadjunctive chemoradiation therapy in pancreatic cancer
    • Willett CG, Daly WJ, Warshaw AL. CA 19-9 is an index of response to neoadjunctive chemoradiation therapy in pancreatic cancer. Am J Surg. 1996;172:350-352.
    • (1996) Am J Surg , vol.172 , pp. 350-352
    • Willett, C.G.1    Daly, W.J.2    Warshaw, A.L.3
  • 34
    • 0038199686 scopus 로고    scopus 로고
    • CA 19-9 in the therapy monitoring and follow-up of locally advanced cancer of the exocrine pancreas treated with radiochemotherapy
    • Micke O, Bruns F, Schafer U, et al. CA 19-9 in the therapy monitoring and follow-up of locally advanced cancer of the exocrine pancreas treated with radiochemotherapy. Anticancer Res. 2003;23:835-840. (Pubitemid 36750881)
    • (2003) Anticancer Research , vol.23 , Issue.2 A , pp. 835-840
    • Micke, O.1    Bruns, F.2    Schafer, U.3    Kurowski, R.4    Horst, E.5    Willich, N.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.